GLP-1 under the scanner Gold rush: Raids across India expose easy availability of weight-loss drug

NEW DELHI: Growing demand for diet pills has now come to the attention of India’s drug regulator, with a series of raids across the country revealing how easily these prescription drugs find their way into the hands of consumers.In recent weeks, inspections of 49 locations, ranging from online pharmacy warehouses and wholesalers to retail pharmacies and health clinics, have uncovered vulnerabilities in the way GLP-1 drugs are sold and promoted. For many, treatments that were supposed to be tightly regulated are quickly turning into on-demand products.Originally developed to treat diabetes and certain heart conditions, GLP-1 drugs are growing in popularity as weight loss solutions, driven by social media buzz and growing demand for quick results. Their growing presence in the Indian market, especially with the entry of generic drugs, will only make them more accessible. But that accessibility now raises serious concerns.Officials said the Drug Controller General of India and state regulators have stepped in to curb abuse and plug supply chain loopholes. The focus is on stopping sales without a prescription, checking questionable dispensing practices and combating misleading promotions.Particularly alarming to authorities is the growing network of access to these drugs—not just pharmacies but also online platforms and weight-loss clinics, often without adequate medical oversight.Earlier this month, regulators issued a clear warning to manufacturers banning alternative advertising and indirect promotions that could encourage off-label use or mislead consumers.Doctors warn these are not lifestyle products. Taking GLP-1 medications without proper supervision can cause serious side effects, making self-medication risky.The regulator reiterated that these drugs can be approved in India only under strict conditions and must be prescribed by experts such as endocrinologists or internal medicine specialists, and in some cases, cardiologists.Officials say enforcement will only become more stringent as demand continues to grow. Violators may have their license revoked, be fined and take legal action.